| __timestamp | Amneal Pharmaceuticals, Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 8901000 |
| Thursday, January 1, 2015 | 367054000 | 9574000 |
| Friday, January 1, 2016 | 420770000 | 14695000 |
| Sunday, January 1, 2017 | 507476000 | 8437000 |
| Monday, January 1, 2018 | 946588000 | 12723000 |
| Tuesday, January 1, 2019 | 1273376000 | 51272000 |
| Wednesday, January 1, 2020 | 1364130000 | 50052000 |
| Friday, January 1, 2021 | 1324696000 | 783000 |
| Saturday, January 1, 2022 | 1427596000 | 868000 |
| Sunday, January 1, 2023 | 1573042000 | 123740000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Amneal Pharmaceuticals, Inc. and Geron Corporation, two prominent players, showcase contrasting trends in their cost of revenue from 2014 to 2023. Amneal Pharmaceuticals has seen a staggering 368% increase in its cost of revenue, peaking at approximately $1.57 billion in 2023. This growth reflects their aggressive expansion and scaling strategies. In contrast, Geron Corporation's cost of revenue remained relatively modest, with a notable spike in 2023, reaching around $123 million. This sudden increase could indicate strategic shifts or new product developments. Over the years, Amneal's costs have consistently outpaced Geron's, highlighting their differing business models and market strategies. As the pharmaceutical landscape continues to shift, these trends offer valuable insights into the operational strategies of these companies.
Cost of Revenue: Key Insights for Sanofi and Amneal Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
ADMA Biologics, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.